Vasopressin, urine concentration, and hypertension: A new perspective on an old story

被引：17

作者：

Luft, Friedrich C. ^{[1
]}

机构：

[1] HELIOS Klin, Franz Volhard Clin, Charite, Fac Med, Berlin, Germany

来源：

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2007年 / 2卷 / 02期

关键词：

D O I：

10.2215/CJN.04161206

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：196 / 197

页数：2

共 11 条

[1] Role of vasopressin in essential hypertension: Racial differences
Bakris, G
Bursztyn, M
Gavras, I
Bresnahan, M
Gavras, H
[J]. JOURNAL OF HYPERTENSION, 1997, 15 (05) : 545 - 550
[2] Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans
Bankir, L
Fernandes, S
Bardoux, P
Bouby, N
Bichet, DG
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07): : 1920 - 1928
[3] Ethnic differences in urine concentration: Possible relationship to blood pressure
Bankir, Lise
Perucca, Julie
Weinberger, Myron H.
[J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (02): : 304 - 312
[4] EFFECT OF WATER-INTAKE ON THE PROGRESSION OF CHRONIC-RENAL-FAILURE IN THE 5/6 NEPHRECTOMIZED RAT
BOUBY, N
BACHMANN, S
BICHET, D
BANKIR, L
[J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (04): : F973 - F979
[5] CHRONIC INTRAVENOUS ADMINISTRATION OF V-1 ARGININE-VASOPRESSIN AGONIST RESULTS IN SUSTAINED HYPERTENSION
COWLEY, AW
SZCZEPANSKASADOWSKA, E
STEPNIAKOWSKI, K
MATTSON, D
[J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (02): : H751 - H756
[6] THE RENAL MEDULLA AND HYPERTENSION
COWLEY, AW
MATTSON, DL
LU, SH
ROMAN, RJ
[J]. HYPERTENSION, 1995, 25 (04) : 663 - 673
[7] ELLIOTT P, 1988, BRIT MED J, V297, P319
[8] Chronic V2 vasopressin receptor stimulation increases basal blood pressure and exacerbates deoxycorticosterone acetate-salt hypertension
Fernandes, S
Bruneval, P
Hagege, A
Heudes, D
Ghostine, S
Bouby, N
[J]. ENDOCRINOLOGY, 2002, 143 (07) : 2759 - 2766
[9] DEVELOPMENT OF A NEW STRAIN OF SPONTANEOUSLY HYPERTENSIVE RATS HOMOZYGOUS FOR HYPOTHALAMIC DIABETES-INSIPIDUS
GANTEN, U
RASCHER, W
LANG, RE
DIETZ, R
RETTIG, R
UNGER, T
TAUGNER, R
GANTEN, D
[J]. HYPERTENSION, 1983, 5 (02) : I119 - I128
[10] Is there a cardiovascular rationale for the use of combined vasopressin V1a/V2 receptor antagonists?
Goldsmith, Steven R.
[J]. AMERICAN JOURNAL OF MEDICINE, 2006, 119 : S93 - S96

← 1 2 →